[1]罗亚东,洪国枯,贾鸣,等.HIV-1 Rev蛋白和人DDX3解旋酶对HCV RNA复制影响[J].第三军医大学学报,2015,37(23):2329-2333.
 Luo Yadong,Hong Guoku,Jia Ming,et al.Effect of HIV-1 Rev protein and DDX3 helicase on HCV RNA replication[J].J Third Mil Med Univ,2015,37(23):2329-2333.
点击复制

HIV-1 Rev蛋白和人DDX3解旋酶对HCV RNA复制影响(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
37卷
期数:
2015年第23期
页码:
2329-2333
栏目:
论著
出版日期:
2015-12-15

文章信息/Info

Title:
Effect of HIV-1 Rev protein and DDX3 helicase on HCV RNA replication
作者:
罗亚东洪国枯贾鸣郭艳刘明毛青
第三军医大学西南医院全军感染病研究所,感染病研究重庆市重点实验室
Author(s):
Luo Yadong Hong Guoku Jia Ming Guo Yan Liu Ming Mao Qing

Institute of Infectious Diseases, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China

关键词:
人类免疫缺陷病毒Ⅰ型病毒颗粒蛋白表达调节因子DEAD-box蛋白家族的ATP依赖的RNA解旋酶3丙型肝炎病毒
Keywords:
human immunodeficiency virus type I regulator of virion protein expression DEAD box RNA helicase 3 hepatitis C virus
分类号:
R345; R373.9; R394.3
文献标志码:
A
摘要:

目的      研究人类免疫缺陷病毒Ⅰ型(HIV-1)病毒颗粒蛋白表达调节因子(regulator of virion protein expression, Rev)和DEAD-box蛋白家族ATP依赖的RNA解旋酶3(DDX3)对HCV RNA复制的影响。      方法      利用HCV表达质粒pCDNA3.1-JFH1转染Huh7细胞以构建稳定的HCV细胞复制模型,另构建pCDNA3.1-Rev-Flag-mCherry和pCDNA3.1-DDX3-YFP-Flag的过表达载体,通过PCR、Western blot和核苷酸测序等方法鉴定载体构建成功后,将实验分为2组对照实验,对照组均只将HCV复制质粒转染Huh7细胞:1组实验组为DDX3和HCV RNA复制质粒共转染入Huh7细胞; 2组的实验组为Rev、DDX3和HCV RNA复制质粒共转染入Huh7细胞。最后通过qPCR定量测定各组HCV RNA复制水平并进行比较。      结果      转染后48 h测各组HCV RNA的复制水平,DDX3+HCV RNA复制质粒组中HCV RNA的水平(1.09×107±0.18×107)明显高于单独转染HCV RNA复制质粒组(4.79×106±1.24×106)(P=0.03);而Rev+DDX3+HCV RNA复制质粒组中HCV RNA的水平(1.74×107±0.40×107)明显低于单独转染HCV RNA复制质粒组(4.17×107±0.46×107)( P<0.001)。      结论      成功构建Rev蛋白和DDX3的过表达载体,并初步证明人DDX3解旋酶可促进HCV RNA的复制,而Rev蛋白和DDX3共同作用可抑制HCV RNA的复制。

Abstract:

Objective      To determine the effect of the regulator of HIV-1 virion protein expression (Rev) and a DEAD box RNA helicase (DDX3) on HCV RNA replication.       Methods      pCDNA3.1-Re-Flag-mCherry and pCDNA3.1-DDX3-YFP-Flag were constructed and identified by PCR, Western blotting and DNA sequencing. Then the Huh7 cells were divided into 2 groups, the control group (only HCV RNA replication plasmid was transfected into Huh7 cells) and the experimental group (DDX3 and HCV RNA replication plasmids were co-transfected into Huh7 cells). qPCR was used to detect the level of HCV RNA for the effects of DDX3 and HCV RNA replication plasmids.       Results      In 48 h after transfection, the expression level of HCV RNA was significantly higher in DDX3+HCV RNA replication plasmid group than HCV RNA plasmid group [(1.09±0.18)×107 vs (4.79±1.24)×106, P=0.03]. But the expression level of HCV RNA was significantly lower in Rev+DDX3+HCV RNA replication plasmid group than that of HCV RNA replication HCV RNA plasmid group [(1.74±0.40)×107 vs (4.17±0.46)×106, P<0.001].       Conclusion      The over-expression vector of DDX3 and Rev is successfully constructed, and DDX3 can accelerate the replication of HCV RNA, but Rev combined with DDX3 can inhibit the replication of HCV in vitro.

参考文献/References:

[1]Garten R J, Lai S, Zhang J, et al. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China[J]. Int J Epidemiol, 2004, 33(1): 182-188.
[2]Mao Q, Ray S C, Laeyendecker O, et al. Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies[J]. J Virol, 2001, 75(7): 3259-3267.
[3]Netski D M, Mao Q, Ray S C, et al. Genetic divergence of hepatitis C virus: the role of HIV-related immunosuppression[J]. J Acquir Immune Defic Syndr, 2008, 49(2): 136-141.
[4]Fromentin R, Tardif M R, Tremblay M J. Inefficient fusion due to a lack of attachment receptor/co-receptor restricts productive human immunodeficiency virus type 1 infection in human hepatoma Huh7.5 cells[J]. J Gen Virol, 2011, 92(Pt 3): 587-597.
[5]Upadya M H, Aweya J J, Tan Y J. Understanding the interaction of hepatitis C virus with host DEAD-box RNA helicases[J]. World J Gastroenterol, 2014, 20(11): 2913-2926.
[6]Ariumi Y. Multiple functions of DDX3 RNA helicase in gene regulation, tumorigenesis, and viral infection[J]. Front Genet, 2014, 5: 423.
[7]Yedavalli V S, Neuveut C, Chi Y H, et al. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function [J]. Cell, 2004, 119(3): 381-392.
[8]Lin W, Weinberg E M, Tai A W, et al. HIV increases HCV replication in a TGF-beta1-dependent manner[J]. Gastroenterology, 2008, 134(3): 803-811.
[9]Xiao P, Usami O, Suzuki Y, et al. Characterization of a CD4-independent clinical HIV-1 that can efficiently infect human hepatocytes through chemokine (C-X-C motif) receptor 4[J]. AIDS, 2008, 22(14): 1749-1757.
[10]Pineda J A, Romero-Gomez M, Diaz-Garcia F, et al. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis [J]. Hepatology, 2005, 41(4): 779-789.
[11]Koziel M J, Peters M G. Viral hepatitis in HIV infection [J]. N Engl J Med, 2007, 356(14): 1445-1454.
[12]Kim A Y, Schulze-zur-Wiesch J, Kuntzen T, et al. Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection[J]. PLoS Med, 2006, 3(12): e492.
[13] Data Collection on Adverse Events of Anti-HIV drugs (D: A: D) Study Group, Smith C, Sabin C A, et al. Factors associated with specific causes of death amongst HIV-positive individuals in The D: A: D  Study[J]. AIDS, 2010, 24(10): 1537-1548.
[14]Qurishi N, Kreuzberg C, Luchters G, et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection[J]. Lancet, 2003, 362(9397): 1708-1713.
[15]Barcaui H S, Tavares G C, May S B, et al. Low rates of sustained virologic response with peginterferon plus ribavirin for chronic hepatitis C virus infection in HIV infected patients in Rio de Janeiro, Brazil[J]. PLoS One, 2013, 8(7): e67734.
[16]Pollard V W, Malim M H. The HIV-1 Rev protein[J]. Annu Rev Microiol, 1998, 52: 491-532.
[17]Chao C H, Chen C M, Cheng P L, et al. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor[J]. Cancer Res, 2006, 66(13): 6579-6588.
[18]Shih J W, Tsai T Y, Chao C H, et al. Candidate tumor suppressor DDX3 RNA helicase specifically represses cap-dependent translation by acting as an eIF4E inhibitory protein[J]. Oncogene, 2008, 27(5): 700-714.
[19]Kanai Y, Dohmae N, Hirokawa N. Kinesin transports RNA: isolation and characterization of an RNA-transporting granule[J]. Neuron, 2004, 43(4): 513-525.
[20]Lai M C, Wang S W, Cheng L, et al. Human DDX3 interacts with the HIV-1 Tat protein to facilitate viral mRNA translation[J]. PLoS One, 2013, 8(7): e68665.
[21]Yedavalli V S, Neuveut C, Chi Y H, et al. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function [J].Cell, 2004, 119(3): 381-392.

更新日期/Last Update: 2015-11-30